AVAH in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with AVAH today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Aveanna Healthcare Holdings Inc. employs clinicians to care for children and adults with complex medical needs. Private duty services generate most of its revenue: nurses and caregivers provide skilled nursing, personal care and other support, with Medicaid managed-care plans and state Medicaid programs paying most of the bills. Medicaid managed care is its largest payer category, so patients generally are not the people paying Aveanna directly.
Its smaller home health and hospice business serves mainly elderly patients and receives most of its payment from Medicare. Aveanna also delivers tube-feeding nutrition and other medical products to patients, primarily paid for by Medicaid and Medicaid managed-care plans.
The business depends on referrals from physicians and hospitals, enough qualified nurses and caregivers to deliver care, and reimbursement that covers service costs. Government payment rates are set by law, limiting Aveanna’s ability to pass on higher labor costs. It must document care correctly to collect payment and maintain healthcare licenses and program eligibility. In some states, opening or expanding services also requires prior approval based on local healthcare needs.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Aveanna’s results hinge chiefly on Medicaid and managed-Medicaid payments and caregiver availability in private-duty care—exposure these broader home-care peers only partly capture.
Addus HomeCare and Aveanna both provide personal care, home health and hospice funded substantially by government programs, so home-care payment rates and caregiver costs matter to both. Watch Addus’s payments and staffing costs for help with daily living, especially for elderly, chronically ill or disabled people, as a comparison for Aveanna’s Medicaid-funded care.
BrightSpring Health Services competes with Aveanna to provide home health, hospice, rehabilitation and supportive care for patients with complex medical needs, serving people covered by Medicare, Medicaid and commercial insurance. Watch its revenue from those care services rather than medication dispensing: that is the business that overlaps with Aveanna.
The Pennant Group competes with Aveanna for home health and hospice patients and referrals, but those services account for only a minority of Aveanna’s revenue. Pennant receives payments from government programs, managed-care payers and private-pay patients; watch its home health and hospice patient trends as a comparison for Aveanna’s mainly Medicare-funded care for elderly patients.
Fed Interest Rate Decision
Fed rate decisions shape borrowing costs across the economy, affecting how much Aveanna pays on its mainly SOFR-linked loans and how much cash remains for patient-care operations.
Expected4.0%Last release4.0%
If it comes in above expectations
If rates rise more than expected, interest costs on repricing debt may increase, leaving less cash for Aveanna to staff and provide home-based care and services.
If it comes in below expectations
If rates fall more than expected, interest costs on repricing debt may ease, leaving Aveanna more cash to staff and provide home-based care and services.
BrightSpring Health Services, Inc. earningsBTSG
BrightSpring’s care-services revenue will show whether activity is strengthening or weakening in home health, hospice and related care that overlaps with Aveanna.
Focus on BrightSpring’s care-services revenue, not medication dispensing. Growth would show that activity in the overlapping care businesses is holding up, though it would not by itself prove demand is the cause; a decline would point to weaker activity and potentially less pressure on Aveanna to win the same patients and referrals.
Addus HomeCare Corp. earningsADUS
Addus’s government-funded personal care results will show whether care payments are keeping pace with caregiver costs, offering a comparison for Aveanna’s Medicaid-funded care.
Read Addus’s government-funded personal care revenue alongside caregiver costs. If costs outrun revenue or the business’s margins weaken, payments may not be keeping up with labor, a pressure that could also affect Aveanna’s Medicaid-funded care; stable or improving care economics would suggest the pressure is more manageable, but Addus’s results do not establish Aveanna’s own rates or costs.
Aveanna Healthcare Holdings Inc. earningsThis company
Private Duty Services is Aveanna’s largest business, and this report will show whether care hours and the revenue left after direct service costs are growing together.
Read Private Duty Services care hours alongside revenue per hour and direct cost per hour; the difference is what remains per hour after direct service costs. Rising hours and revenue growing faster than cost would show that Aveanna is serving more care and keeping more per hour; falling hours or costs catching up with revenue would point to weaker growth or a thinner cushion.